Vera Bank, N.A. Abb Vie Inc. Transaction History

Vera Bank, N.A.

$329 Million
Q3 2024

A detailed history of Vera Bank, N.A. transactions in Abb Vie Inc. stock. As of the latest transaction made, Vera Bank, N.A. holds 12,928 shares of ABBV stock, worth $2.3 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

12,928

Previous 12,943 0.12%

Holding current value

$2.3 Million

Previous $2.22 Million 15.05%

% of portfolio

0.78%

Previous 0.72%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$163.84 - $199.33 $2,457 - $2,989	-15 Reduced 0.12%	12,928 $2.55 Million
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $25,411 - $28,953	-159 Reduced 1.21%	12,943 $2.36 Million
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $38,390 - $43,236	279 Added 2.18%	13,102 $2.03 Million
Q3 2023 Oct 24, 2023	BUY	$133.59 - $154.65 $36,737 - $42,528	275 Added 2.19%	12,823 $1.91 Million
Q2 2023 Jul 14, 2023	SELL	$132.51 - $164.9 $107,730 - $134,063	-813 Reduced 6.08%	12,548 $1.69 Million
Q1 2023 Apr 20, 2023	SELL	$144.61 - $166.54 $5,784 - $6,661	-40 Reduced 0.3%	13,361 $2.13 Million
Q4 2022 Jan 25, 2023	BUY	$138.31 - $165.87 $6,362 - $7,630	46 Added 0.34%	13,401 $0
Q3 2022 Oct 06, 2022	SELL	$134.21 - $153.93 $22,010 - $25,244	-164 Reduced 1.21%	13,355 $1.79 Million
Q2 2022 Jul 28, 2022	BUY	$137.62 - $174.96 $154,822 - $196,830	1,125 Added 9.08%	13,519 $2.07 Million
Q1 2022 Apr 27, 2022	SELL	$131.98 - $163.75 $68,761 - $85,313	-521 Reduced 4.03%	12,394 $2.01 Million
Q4 2021 Feb 04, 2022	BUY	$107.43 - $135.93 $15,469 - $19,573	144 Added 1.13%	12,915 $1.75 Million
Q3 2021 Oct 07, 2021	BUY	$106.4 - $120.78 $27,664 - $31,402	260 Added 2.08%	12,771 $1.38 Million
Q2 2021 Aug 04, 2021	BUY	$105.21 - $117.21 $12,519 - $13,947	119 Added 0.96%	12,511 $1.41 Million
Q1 2020 Apr 21, 2020	BUY	$64.5 - $97.79 $90,300 - $136,906	1,400 Added 12.74%	12,392 $944,000
Q4 2019 Jan 27, 2020	BUY	$72.13 - $90.25 $100,982 - $126,350	1,400 Added 14.6%	10,992 $973,000
Q3 2019 Oct 11, 2019	SELL	$62.98 - $75.72 $23,176 - $27,864	-368 Reduced 3.69%	9,592 $726,000
Q2 2019 Jul 24, 2019	SELL	$65.7 - $83.98 $13,797 - $17,635	-210 Reduced 2.06%	9,960 $724,000
Q1 2019 Apr 23, 2019	SELL	$77.14 - $90.79 $7,714 - $9,079	-100 Reduced 0.97%	10,170 $819,000
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $799,519 - $986,022	10,270 New	10,270 $947,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vera Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Vera Bank, N.A. with notifications on news.

Account